Monactil (Dexibuprofen)

Dexibuprofen works by reversibly blocking the cyclo‑oxygenase‑1 and cyclo‑oxygenase‑2 (COX‑1/COX‑2) enzymes. This inhibition prevents the formation of prostaglandins, which are mediators of inflammation, pain, and fever. By lowering prostaglandin levels, dexibuprofen reduces the sensation of pain and the physiological processes that cause swelling and elevated temperature.

The appropriate dose of Monactil is determined by a qualified healthcare professional based on the individual’s condition, age, weight and overall health. Physicians typically prescribe a dose that balances efficacy with safety, and patients should follow the prescriber’s instructions without altering the regimen on their own.

Safety data for dexibuprofen in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the use of Monactil with their obstetrician or physician before starting therapy.

To request Monactil, visit the product page on gnhindia.com, enter the desired quantity and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any required temperature control) and assistance with import documentation.

Dexibuprofen is the S‑enantiomer of ibuprofen, which means it provides the same analgesic and anti‑inflammatory effects at roughly half the dose of racemic ibuprofen. This can result in a more favorable safety profile, particularly regarding gastrointestinal tolerance, while maintaining comparable efficacy for pain and inflammation.

Monactil tablets should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original blister pack or container, protect it from moisture, humidity and direct sunlight, and ensure that it is out of reach of children.

Monactil is taken orally with a full glass of water. It can be taken with or without food, although taking it with food may reduce the likelihood of stomach discomfort. Patients should swallow the tablet whole and avoid crushing or chewing it unless directed by a healthcare professional.

The most serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, and renal impairment, especially in patients with pre‑existing kidney disease or dehydration. Prompt medical attention is required if symptoms like severe abdominal pain, black stools, sudden swelling, or shortness of breath occur.

Monactil should be avoided by individuals with a known hypersensitivity to dexibuprofen or other NSAIDs, active peptic ulcer disease, severe heart failure, uncontrolled hypertension, or significant renal or hepatic impairment. It is also contraindicated in patients who have recently undergone coronary artery bypass graft surgery.